ST GLIPTIN GM 50+2+500 by Steris Healthcare — Complete Guide to Uses, Dosage & Precautions

 ST GLIPTIN GM 50+2+500, manufactured by Steris Healthcare, is a triple-drug combination tablet containing Sitagliptin 50mg, Metformin Hydrochloride 500mg, and Glimepiride 2mg, prescribed for the management of Type 2 diabetes mellitus in adults who require more intensive glycemic control than diet, exercise, or single or dual-drug therapy can achieve. This combination addresses blood sugar regulation through three distinct and complementary mechanisms: Sitagliptin enhances the body's own incretin hormone activity to boost insulin release in a glucose-dependent manner, Metformin reduces hepatic glucose production and improves insulin sensitivity, and Glimepiride directly stimulates pancreatic insulin secretion. Together, they offer robust, multi-pathway glycemic control in a single convenient tablet.

Why It's Important

Type 2 diabetes is a progressive condition, and many patients eventually find that dual-drug therapy is insufficient to maintain target HbA1c and blood glucose levels as insulin resistance and beta-cell decline advance over time. Escalating to a third mechanism of action, rather than simply increasing the dose of existing medications, allows for more comprehensive glucose control while often minimizing the incremental side-effect burden associated with maximizing a single drug class. ST GLIPTIN GM 50+2+500 is important because it combines an incretin-based therapy, known for its relatively lower hypoglycemia risk and glucose-dependent action, with the well-established combination of Metformin and Glimepiride — offering physicians a practical, single-tablet option for patients needing intensified therapy without adding multiple separate prescriptions to their daily regimen.

Key Benefits 

What are the benefits?

  • Comprehensive blood glucose control through three complementary mechanisms
  • Glucose-dependent insulin enhancement via Sitagliptin reduces excess hypoglycemia risk
  • Improves insulin sensitivity and reduces hepatic glucose output
  • Simplifies treatment regimen with a single combination tablet
  • Manufactured under WHO-GMP and ISO 9001:2018 certified facility standards by Steris Healthcare, ensuring consistent quality and reliability

Side Effects

Common side effects may include nausea, diarrhea, bloating, headache, and mild upper respiratory symptoms, particularly during initial use.

Serious Side Effects 

Seek immediate medical attention for signs of hypoglycemia (sweating, shakiness, confusion, fainting), signs of pancreatitis (severe abdominal pain radiating to the back, persistent vomiting), signs of lactic acidosis (unusual muscle pain, difficulty breathing), or signs of a severe allergic reaction such as facial swelling or difficulty breathing.

Available Substitute 

Several branded Sitagliptin, Metformin, and Glimepiride triple-combination formulations are available in the Indian market at comparable strengths. Brand switches should only be made under physician guidance to maintain stable glycemic control.

Dosage Guidelines 

Dosage is individualized by the treating physician based on blood glucose levels and patient response, typically taken with the first bite of a main meal to optimize glucose control and reduce gastrointestinal side effects. Regular blood glucose monitoring is recommended. Missed doses should not be doubled.

Precautions & Warnings

Use cautiously in patients with renal or hepatic impairment, and avoid use in those with a history of pancreatitis or lactic acidosis. Alcohol should be limited, as it can increase the risk of hypoglycemia and lactic acidosis. Inform your doctor of all current medications before starting therapy.

Mechanism of Action

Sitagliptin inhibits the DPP-4 enzyme, prolonging the activity of incretin hormones that stimulate glucose-dependent insulin release and suppress glucagon secretion. Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity. Glimepiride stimulates pancreatic beta-cells to release insulin directly, together providing broad-spectrum glycemic control across multiple pathways.

Conclusion

ST GLIPTIN GM 50+2+500 by Steris Healthcare offers a comprehensive, triple-action approach to Type 2 diabetes management for patients requiring intensified glycemic control. Treatment should be guided by a physician with regular monitoring for optimal long-term outcomes.

Comments

Post a Comment

Popular posts from this blog

Steris Healthcare: Committed to Quality Healthcare and Pharmaceutical Excellence

 Healthcare is one of the most significant sectors influencing the well-being of individuals and communities. As medical science advances, the demand for reliable pharmaceutical products continues to grow. Patients, healthcare professionals, and medical institutions all depend on high-quality medicines that meet strict standards of safety and effectiveness. Pharmaceutical companies play a vital role in ensuring these products are developed, manufactured, and delivered responsibly. Steris Healthcare is committed to supporting better healthcare by providing quality pharmaceutical products designed to improve patient outcomes. Guided by innovation, integrity, and continuous improvement, the company strives to meet the evolving needs of the healthcare industry while maintaining high standards of quality and customer satisfaction. A Vision for Better Healthcare Every successful healthcare organization begins with a clear vision. Steris Healthcare believes that quality medicines and de...
Read more

N-Acetyl L-Cysteine (NAC), Pine Bark Extract and Resveratrol Tablets for Daily Wellness

Image
  N-Acetyl L-Cysteine (NAC), Pine Bark Extract & Resveratrol Tablets: Ingredients and Health Benefits Today’s lifestyle in India has changed a lot. Long working hours, stress, pollution, processed food, and lack of physical activity are affecting overall health. Many people feel tired, low on energy, or struggle with metabolic and hormonal balance tablet . One of the main reasons behind this is oxidative stress. Oxidative stress happens when harmful molecules called free radicals damage the body’s cells. Over time, this may affect immunity, liver health, heart health, skin, and overall wellness.  STYLECYSTIN ENDO is a specially designed antioxidant tablet that contains N-Acetyl L-Cysteine (NAC), Pine Bark Extract, and Resveratrol . This powerful combination supports cellular protection, improves antioxidant levels, and promotes better internal balance. It is commonly recommended as supportive therapy in metabolic conditions, women’s health concerns, and lifestyle-related ...
Read more
Megestrol Acetate 160 mg: MAGRAL 160 Uses, Benefits & Safety MAGRAL 160 contains Megestrol Acetate 160 mg and is marketed by Steris Healthcare . Megestrol acetate is a synthetic progestin that is used in specific clinical situations, particularly for managing anorexia, cachexia, or significant unexplained weight loss associated with advanced cancer or AIDS , depending on the approved indication and medical judgment. It is a prescription medicine and should be used under the supervision of a qualified healthcare professional. Megestrol acetate is not a general-purpose appetite booster or routine weight-gain medicine. Before treatment, the underlying reason for poor appetite or weight loss should be evaluated. What is MAGRAL 160 For? MAGRAL 160 may be prescribed when significant appetite loss or involuntary weight loss occurs in certain serious medical conditions. Megestrol acetate can help increase appetite and may contribute to weight gain in appropriately selected patients. Th...
Read more